ArticleAntimicrobial agents and chemotherapy2005

TAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humans.

Masanori Baba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.